Diagnosis and management of cerebral venous thrombosis: A statement for healthcare professionals from the American Heart Association/American Stroke Association

Stroke

Volumn 42, Issue 4, 2011, Pages 1158-1192

  Saposnik, Gustavo ^a   Barinagarrementeria, Fernando ^a   Brown, Robert D ^a   Bushnell, Cheryl D ^a   Cucchiara, Brett ^a   Cushman, Mary ^a   Deveber, Gabrielle ^a   Ferro, Jose M ^a   Tsai, Fong Y ^a  

^a NONE

Author keywords

AHA Scientific Statements; anticoagulants; brain infarction, venous; children; disease management; outcome assessment; pregnancy; prognosis; sinus thrombosis, intracranial; stroke; venous thrombosis

Indexed keywords

ACETAZOLAMIDE; ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTITHROMBIN III; ANTIVITAMIN K; BLOOD CLOTTING FACTOR 5 LEIDEN; CARDIOLIPIN ANTIBODY; CONTRAST MEDIUM; D DIMER; FIBRINOLYTIC AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; ORAL CONTRACEPTIVE AGENT; PHOSPHOLIPID ANTIBODY; PLACEBO; PROTEIN C; PROTEIN S; PROTHROMBIN; STEROID;

ACTIVATED PROTEIN C RESISTANCE; ANTICOAGULANT THERAPY; ANTICONVULSANT THERAPY; ANTITHROMBIN III DEFICIENCY; ARTICLE; ARTIFACT; BLOOD CLOT LYSIS; BLOOD EXAMINATION; BRAIN ANGIOGRAPHY; BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN INFECTION; CEREBRAL VEIN THROMBOSIS; CEREBROSPINAL FLUID ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CONTRAST ENHANCEMENT; DEATH; DECOMPRESSIVE CRANIECTOMY; DIAGNOSTIC ERROR; DRUG EFFICACY; DURAL ARTERIOVENOUS FISTULA; ECHOGRAPHY; FIBRINOLYTIC THERAPY; FOCAL EPILEPSY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GRAND MAL SEIZURE; HEADACHE; HEALTH CARE ORGANIZATION; HUMAN; HYDROCEPHALUS; HYPERHOMOCYSTEINEMIA; INCIDENCE; INTRACRANIAL HYPERTENSION; LUMBAR PUNCTURE; MAGNETIC RESONANCE ANGIOGRAPHY; MENTAL DISEASE; MENTAL HEALTH; NEOPLASM; NEUROLOGICAL COMPLICATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; OCCLUSIVE CEREBROVASCULAR DISEASE; ORAL CONTRACEPTION; PHLEBOGRAPHY; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; PUERPERIUM; RECURRENCE RISK; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SECONDARY PREVENTION; SEIZURE; SENSITIVITY AND SPECIFICITY; STEROID THERAPY; SURGICAL THROMBECTOMY; THROMBECTOMY; THROMBOGENESIS; THROMBOPHILIA; THROMBOSIS; VEIN THROMBOSIS; VISUAL IMPAIRMENT;

CHILD; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; INTRACRANIAL THROMBOSIS; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; VENOUS THROMBOSIS;

EID: 79954807077     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STR.0b013e31820a8364     Document Type: Article

References (286)

1. Bousser MG, Ferro JM. Cerebral venous thrombosis: an update. Lancet Neurol. 2007;6:162-170. (Pubitemid 46097542)
2. Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med. 2005;352:1791-1798.
3. Stam J. Cerebral venous and sinus thrombosis: incidence and causes. Adv Neurol. 2003;92:225-232.
4. Ferro JM. Causes, predictors of death, and antithrombotic treatment in cerebral venous thrombosis. Clin Adv Hematol Oncol. 2006;4:732-733. (Pubitemid 44794702)
5. Gibbons RJ, Smith S, Antman E. American College of Cardiology/ American Heart Association clinical practice guidelines: part I: where do they come from? Circulation. 2003;107:2979-2986. (Pubitemid 36736643)
6. Canhão P, Ferro JM, Lindgren AG, Bousser MG, Stam J, Barinagarrementeria F; ISCVT Investigators. Causes and predictors of death in cerebral venous thrombosis. Stroke. 2005;36:1720-1725. (Pubitemid 41098769)
7. Towbin A. The syndrome of latent cerebral venous thrombosis: its frequency and relation to age and congestive heart failure. Stroke. 1973;4:419-430.
8. Cantu C, Arauz A, Ruiz-Sandoval JL, Barinagarrementeria F, Villarreal J, Rangel R, Murillo-Bonilla L. Clinical outcome and stroke types in Hispanic mestizos. Presented at: Joint World Congress of Stroke; October 26-29, 2006; Cape Town, South Africa.
9. Janghorbani M, Zare M, Saadatnia M, Mousavi SA, Mojarrad M, Asgari E. Cerebral vein and dural sinus thrombosis in adults in Isfahan, Iran: frequency and seasonal variation. Acta Neurol Scand. 2008;117: 117-121.
10. Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F; ISCVT Investigators. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004;35:664-670. (Pubitemid 38280838)
11. de Freitas GR, Bogousslavsky J. Risk factors of cerebral vein and sinus thrombosis. Front Neurol Neurosci. 2008;23:23-54.
12. Bombeli T, Basic A, Fehr J. Prevalence of hereditary thrombophilia in patients with thrombosis in different venous systems. Am J Hematol. 2002;70:126-132.
13. Martinelli I, Battaglioli T, Pedotti P, Cattaneo M, Mannucci PM. Hyperhomocysteinemia in cerebral vein thrombosis. Blood. 2003;102: 1363-1366. (Pubitemid 36988044)
14. Wasay M, Bakshi R, Bobustuc G, Kojan S, Sheikh Z, Dai A, Cheema Z. Cerebral venous thrombosis: analysis of a multicenter cohort from the United States. J Stroke Cerebrovasc Dis. 2008;17:49-54. (Pubitemid 351381440)
15. Christopher R, Nagaraja D, Dixit NS, Narayanan CP. Anticardiolipin antibodies: a study in cerebral venous thrombosis. Acta Neurol Scand. 1999;99:121-124. (Pubitemid 29064319)
16. Boncoraglio G, Carriero MR, Chiapparini L, Ciceri E, Ciusani E, Erbetta A, Parati EA. Hyperhomocysteinemia and other thrombophilic risk factors in 26 patients with cerebral venous thrombosis. Eur J Neurol. 2004;11:405-409. (Pubitemid 39272945)
17. Ventura P, Cobelli M, Marietta M, Panini R, Rosa MC, Salvioli G. Hyperhomocysteinemia and other newly recognized inherited coagulation disorders (factor V Leiden and prothrombin gene mutation) in patients with idiopathic cerebral vein thrombosis. Cerebrovasc Dis. 2004;17:153-159. (Pubitemid 38529191)
18. Gadelha T, André C, Jucá AA, Nucci M. Prothrombin 20210A and oral contraceptive use as risk factors for cerebral venous thrombosis. Cerebrovasc Dis. 2005;19:49-52. (Pubitemid 40082258)
19. Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA. 1993;90:1004-1008. (Pubitemid 23053939)
20. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369:64-67. (Pubitemid 24144355)
21. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3α-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996;88:3698-3703. (Pubitemid 26383091)
22. Weih M, Vetter B, Ziemer S, Mehraein S, Valdueza JM, Koscielny J, Kulozik AE, Einhäupl KM. Increased rate of factor V Leiden mutation in patients with cerebral venous thrombosis. J Neurol. 1998;245: 149-152. (Pubitemid 28135057)
23. Rodrigues CA, Rocha LK, Morelli VM, Franco RF, Lourençco DM. Prothrombin G20210A mutation, and not factor V Leiden mutation, is a risk factor for cerebral venous thrombosis in Brazilian patients. J Thromb Haemost. 2004;2:1211-1212. (Pubitemid 40186105)
24. Meng Q, Pu C. Cerebral venous thrombosis and factor V Leiden mutation [in Chinese]. Zhonghua Yi Xue Za Zhi. 2002;82:47-49.
25. Voetsch B, Damasceno BP, Camargo EC, Massaro A, Bacheschi LA, Scaff M, Annichino-Bizzacchi JM, Arruda VR. Inherited thrombophilia as a risk factor for the development of ischemic stroke in young adults. Thromb Haemost. 2000;83:229-233. (Pubitemid 30093224)
26. Zuber M, Toulon P, Marnet L, Mas JL. Factor V Leiden mutation in cerebral venous thrombosis. Stroke. 1996;27:1721-1723. (Pubitemid 26332492)
27. Martinelli I, Landi G, Merati G, Cella R, Tosetto A, Mannucci PM. Factor V gene mutation is a risk factor for cerebral venous thrombosis. Thromb Haemost. 1996;75:393-394. (Pubitemid 26099700)
28. Dentali F, Crowther M, Ageno W. Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: a meta-analysis. Blood. 2006;107:2766-2773.
29. Cantu C, Alonso E, Jara A, Martínez L, Ríos C, Fernández M, Garcia I, Barinagarrementeria F. Hyperhomocysteinemia, low folate and vitamin B12 concentrations, and methylene tetrahydrofolate reductase mutation in cerebral venous thrombosis. Stroke. 2004;35:1790-1794. (Pubitemid 38971852)
30. Nagaraja D, Noone ML, Bharatkumar VP, Christopher R. Homocysteine, folate and vitamin B(12) in puerperal cerebral venous thrombosis. J Neurol Sci. 2008;272:43-47.
31. James AH, Bushnell CD, Jamison MG, Myers ER. Incidence and risk factors for stroke in pregnancy and the puerperium. Obstet Gynecol. 2005;106:509-516. (Pubitemid 41208782)
32. Cantú C, Barinagarrementeria F. Cerebral venous thrombosis associated with pregnancy and puerperium: review of 67 cases. Stroke. 1993;24: 1880-1884. (Pubitemid 23352719)
33. Jaigobin C, Silver FL. Stroke and pregnancy. Stroke. 2000;31: 2948-2951.
34. Davie CA, O'Brien P. Stroke and pregnancy. J Neurol Neurosurg Psychiatry. 2008;79:240-245. (Pubitemid 351303375)
35. Lanska DJ, Kryscio RJ. Risk factors for peripartum and postpartum stroke and intracranial venous thrombosis. Stroke. 2000;31:1274-1282. (Pubitemid 30351245)
36. Martinelli I, Sacchi E, Landi G, Taioli E, Duca F, Mannucci PM. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med. 1998;338: 1793-1797. (Pubitemid 28277959)
37. de Bruijn SF, Stam J, Koopman MM, Vandenbroucke JP; the Cerebral Venous Sinus Thrombosis Study Group. Case-control study of risk of cerebral sinus thrombosis in oral contraceptive users and in [correction of who are] carriers of hereditary prothrombotic conditions. BMJ. 1998; 316:589-592. (Pubitemid 28120990)
38. Reuner KH, Ruf A, Grau A, Rickmann H, Stolz E, Jüttler E, Druschky KF, Patscheke H. Prothrombin gene G202103A transition is a risk factor for cerebral venous thrombosis. Stroke. 1998;29:1765-1769. (Pubitemid 28399961)
39. Kim AW, Trobe JD. Syndrome simulating pseudotumor cerebri caused by partial transverse venous sinus obstruction in metastatic prostate cancer. Am J Ophthalmol. 2000;129:254-256. (Pubitemid 30089291)
40. Meininger V, James JM, Rio B, Zittoun R. Dural venous sinus occlusions in hemopathies [in French]. Rev Neurol (Paris). 1985;141: 228-233. (Pubitemid 15033111)
41. Raizer JJ, DeAngelis LM. Cerebral sinus thrombosis diagnosed by MRI and MR venography in cancer patients. Neurology. 2000;54:1222-1226. (Pubitemid 30174037)
42. Damak M, Crassard I, Wolff V, Bousser MG. Isolated lateral sinus thrombosis: a series of 62 patients. Stroke. 2009;40:476-481.
43. Wasay M, Dai AI, Ansari M, Shaikh Z, Roach ES. Cerebral venous sinus thrombosis in children: a multicenter cohort from the United States. J Child Neurol. 2008;23:26-31.
44. Manolidis S, Kutz JW Jr. Diagnosis and management of lateral sinus thrombosis. Otol Neurotol. 2005;26:1045-1051. (Pubitemid 41330726)
45. Kueper M, Goericke SL, Kastrup O. Cerebral venous thrombosis after epidural blood patch: coincidence or causal relation? A case report and review of the literature. Cephalalgia. 2008;28:769-773. (Pubitemid 351799745)
46. Lan MY, Chang YY, Liu JS. Delayed cerebral venous thrombosis in a patient with spontaneous intracranial hypotension. Cephalalgia. 2007; 27:1176-1178.
47. Wilder-Smith E, Kothbauer-Margreiter I, Lämmle B, Sturzenegger M, Ozdoba C, Hauser SP. Dural puncture and activated protein C resistance: risk factors for cerebral venous sinus thrombosis. J Neurol Neurosurg Psychiatry. 1997;63:351-356. (Pubitemid 27412378)
48. Misra UK, Kalita J, Bansal V, Nair PP. Paroxysmal nocturnal haemoglobinuria presenting as cerebral venous sinus thrombosis. Transfus Med. 2008;18:308-311.
49. Ogata T, Kamouchi M, Kitazono T, Kuroda J, Ooboshi H, Shono T, Morioka T, Ibayashi S, Sasaki T, Iida M. Cerebral venous thrombosis associated with iron deficiency anemia. J Stroke Cerebrovasc Dis. 2008;17:426-428.
50. Alper G, Berrak SG, Ekinci G, Canpolat C, Erzen C. Sagittal sinus thrombosis associated with thrombocytopenia: a report of two patients. Pediatr Neurol. 1999;21:573-575. (Pubitemid 29366828)
51. Zaragoza-Casares P, Gómez-Fernández T, Zato-Gómez de Liaño MA, Zaragoza-García P. Superior sagittal sinus thrombosis and bilateral sixth-nerve palsy in a child with nephrotic syndrome. Pediatr Nephrol. 2007;22:753-755. (Pubitemid 46691536)
52. Appenzeller S, Faria A, Marini R, Costallat LT, Cendes F. Focal transient lesions of the corpus callosum in systemic lupus erythematosus. Clin Rheumatol. 2006;25:568-571. (Pubitemid 44137643)
53. Borhani-Haghighi A, Samangooie S, Ashjazadeh N, Nikseresht A, Shariat A, Yousefipour G, Safari A. Neurological manifestations of Behçcet's disease. Saudi Med J. 2006;27:1542-1546.
54. Grimes DA, Schulz KF. Bias and causal associations in observational research. Lancet. 2002;359:248-252. (Pubitemid 34113828)
55. Varga EA, Moll S. Cardiology patient pages: prothrombin 20210 mutation (factor II mutation). Circulation. 2004;110:e15-e18.
56. Tosetto A, Missiaglia E, Frezzato M, Rodeghiero F. The VITA project: prothrombin G20210A mutation and venous thromboembolism in the general population. Thromb Haemost. 1999;82:1395-1398. (Pubitemid 29527626)
57. Pabinger I, Grafenhofer H, Kyrle PA, Quehenberger P, Mannhalter C, Lechner K, Kaider A. Temporary increase in the risk for recurrence during pregnancy in women with a history of venous thromboembolism. Blood. 2002;100:1060-1062. (Pubitemid 34832638)
58. Ruíz-Sandoval JL, Cantú C, Barinagarrementeria F. Intracerebral hemorrhage in young people: analysis of risk factors, location, causes, and prognosis. Stroke. 1999;30:537-541. (Pubitemid 29115388)
59. Gillum LA, Mamidipudi SK, Johnston SC. Ischemic stroke risk with oral contraceptives: a meta-analysis. JAMA. 2000;284:72-78. (Pubitemid 30445664)
60. Rogers LR. Cerebrovascular complications in patients with cancer. Semin Neurol. 2004;24:453-460. (Pubitemid 40076121)
61. Gosk-Bierska I, Wysokinski W, Brown RD Jr, Karnicki K, Grill D, Wiste H, Wysokinska E, McBane RD 2nd. Cerebral venous sinus thrombosis: incidence of venous thrombosis recurrence and survival. Neurology. 2006; 67:814-819. (Pubitemid 44394195)
62. De Cruz P, Lust M, Trost N, Wall A, Gerraty R, Connell WR. Cerebral venous thrombosis associated with ulcerative colitis. Intern Med J. 2008;38:865-867.
63. Khealani BA, Wasay M, Saadah M, Sultana E, Mustafa S, Khan FS, Kamal AK. Cerebral venous thrombosis: a descriptive multicenter study of patients in Pakistan and Middle East. Stroke. 2008;39:2707-2711.
64. Cumurciuc R, Crassard I, Sarov M, Valade D, Bousser MG. Headache as the only neurological sign of cerebral venous thrombosis: a series of 17 cases. J Neurol Neurosurg Psychiatry. 2005;76:1084-1087. (Pubitemid 41081281)
65. Crassard I, Bousser MG. Headache in patients with cerebral venous thrombosis [in French]. Rev Neurol (Paris). 2005;161:706-708. (Pubitemid 40934014)
66. Appenzeller S, Zeller CB, Annichino-Bizzachi JM, Costallat LT, Deus-Silva L, Voetsch B, Faria AV, Zanardi VA, Damasceno BP, Cendes F. Cerebral venous thrombosis: influence of risk factors and imaging findings on prognosis. Clin Neurol Neurosurg. 2005;107: 371-378. (Pubitemid 40980380)
67. Biousse V, Ameri A, Bousser MG. Isolated intracranial hypertension as the only sign of cerebral venous thrombosis. Neurology. 1999;53: 1537-1542. (Pubitemid 29491950)
68. Patronas NJ, Duda EE, Mirfakhraee M, Wollmann RL. Superior sagittal sinus thrombosis diagnosed by computed tomography. Surg Neurol. 1981;15:11-14. (Pubitemid 11141680)
69. Teichgraeber JF, Per-Lee JH, Turner JS Jr. Lateral sinus thrombosis: a modern perspective. Laryngoscope. 1982;92(pt 1):744-751. (Pubitemid 12090470)
70. Leach JL, Fortuna RB, Jones BV, Gaskill-Shipley MF. Imaging of cerebral venous thrombosis: current techniques, spectrum of findings, and diagnostic pitfalls. Radiographics. 2006;26(suppl 1):S19-S41.
71. Sagduyu A, Sirin H, Mulayim S, Bademkiran F, Yunten N, Kitis O, Calli C, Dalbasti T, Kumral E. Cerebral cortical and deep venous thrombosis without sinus thrombosis: clinical MRI correlates. Acta Neurol Scand. 2006;114:254-260. (Pubitemid 44337244)
72. van den Bergh WM, van der Schaaf I, van Gijn J. The spectrum of presentations of venous infarction caused by deep cerebral vein thrombosis. Neurology. 2005;65:192-196. (Pubitemid 41022360)
73. Crombé D, Haven F, Gille M. Isolated deep cerebral venous thrombosis diagnosed on CT and MR imaging: a case study and literature review. JBR-BTR. 2003;86:257-261. (Pubitemid 37377017)
74. Tsai FY, Kostanian V, Rivera M, Lee KW, Chen CC, Nguyen TH. Cerebral venous congestion as indication for thrombolytic treatment. Cardiovasc Intervent Radiol. 2007;30:675-687. (Pubitemid 350103101)
75. Yamini B, Loch Macdonald R, Rosenblum J. Treatment of deep cerebral venous thrombosis by local infusion of tissue plasminogen activator. Surg Neurol. 2001;55:340-346.
76. Jones BV. Case 62: lobar hemorrhage from thrombosis of the vein of Labbé. Radiology. 2003;228:693-696. (Pubitemid 37025477)
77. Cucchiara B, Messe S, Taylor R, Clarke J, Pollak E. Utility of D-dimer in the diagnosis of cerebral venous sinus thrombosis. J Thromb Haemost. 2005;3:387-389. (Pubitemid 41623631)
78. Lalive PH, de Moerloose P, Lovblad K, Sarasin FP, Mermillod B, Sztajzel R. Is measurement of D-dimer useful in the diagnosis of cerebral venous thrombosis? Neurology. 2003;61:1057-1060. (Pubitemid 37461937)
79. Tardy B, Tardy-Poncet B, Viallon A, Piot M, Garnier P, Mohamedi R, Guyomarc'h S, Venet C. D-dimer levels in patients with suspected acute cerebral venous thrombosis. Am J Med. 2002;113:238-241. (Pubitemid 35245635)
80. Wildberger JE, Mull M, Kilbinger M, Schon S, Vorwerk D. Cerebral sinus thrombosis: rapid test diagnosis by demonstration of increased plasma D-dimer levels (SimpliRED) [in German]. Rofo. 1997;167: 527-529.
81. Talbot K, Wright M, Keeling D. Normal d-dimer levels do not exclude the diagnosis of cerebral venous sinus thrombosis. J Neurol. 2002;249: 1603-1604. (Pubitemid 35477908)
82. Kosinski CM, Mull M, Schwarz M, Koch B, Biniek R, Schläfer J, Milkereit E, Willmes K, Schiefer J. Do normal D-dimer levels reliably exclude cerebral sinus thrombosis? Stroke. 2004;35:2820-2825. (Pubitemid 39565177)
83. Crassard I, Soria C, Tzourio C, Woimant F, Drouet L, Ducros A, Bousser MG. A negative D-dimer assay does not rule out cerebral venous thrombosis: a series of seventy-three patients. Stroke. 2005;36: 1716-1719. (Pubitemid 41098768)
84. Girot M, Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F, Leys D; ISCVT Investigators. Predictors of outcome in patients with cerebral venous thrombosis and intracerebral hemorrhage. Stroke. 2007;38:337-342. (Pubitemid 46184304)
85. Lin A, Foroozan R, Danesh-Meyer HV, De Salvo G, Savino PJ, Sergott RC. Occurrence of cerebral venous sinus thrombosis in patients with presumed idiopathic intracranial hypertension. Ophthalmology. 2006; 113:2281-2284. (Pubitemid 44838923)
86. Nagi S, Kaddour C, Soukri I, Ben Ghorbal I, Sebai R, Belghith L, Skandrani L, Touibi S. Deep cerebral venous system thrombosis: report of two cases [in French]. J Radiol. 2006;87:1084-1088. (Pubitemid 44284708)
87. Nakazato Y, Sonoda K, Senda M, Tamura N, Araki N, Tanahashi N, Shimazu K. Case of straight sinus venous thrombosis presenting as depression and disorientation due to bilateral thalamic lesions [in Japanese]. Rinsho Shinkeigaku. 2006;46:652-654. (Pubitemid 46212249)
88. Kothare SV, Ebb DH, Rosenberger PB, Buonanno F, Schaefer PW, Krishnamoorthy KS. Acute confusion and mutism as a presentation of thalamic strokes secondary to deep cerebral venous thrombosis. J Child Neurol. 1998;13:300-303. (Pubitemid 28432162)
89. Ferro JM, Canhão P, Bousser MG, Stam J, Barinagarrementeria F; ISCVT Investigators. Cerebral vein and dural sinus thrombosis in elderly patients. Stroke. 2005;36:1927-1932. (Pubitemid 41266529)
90. Terazzi E, Mittino D, Rudá R, Cerrato P, Monaco F, Sciolla R, Grasso E, Leone MA; Cerebral Venous Thrombosis Group. Cerebral venous thrombosis: a retrospective multicentre study of 48 patients. Neurol Sci. 2005;25:311-315. (Pubitemid 40347908)
91. Tsai FY, Nguyen B, Lin WC, Hsueh CJ, Yen A, Meng K, Kostanian V. Endovascular procedures for cerebrovenous disorders. Acta Neurochir Suppl. 2008;101:83-86.
92. Justich E, Lammer J, Fritsch G, Beitzke A, Walter GF. CT diagnosis of thrombosis of dural sinuses in childhood. Eur J Radiol. 1984;4: 294-295. (Pubitemid 15195480)
93. Ford K, Sarwar M. Computed tomography of dural sinus thrombosis. AJNR Am J Neuroradiol. 1981;2:539-543. (Pubitemid 12220609)
94. Linn J, Ertl-Wagner B, Seelos KC, Strupp M, Reiser M, Brückmann H, Brüning R. Diagnostic value of multidetector-row CT angiography in the evaluation of thrombosis of the cerebral venous sinuses. AJNR Am J Neuroradiol. 2007;28:946-952. (Pubitemid 46776081)
95. Tsai FY, Wang AM, Matovich VB, Lavin M, Berberian B, Simonson TM, Yuh WT. MR staging of acute dural sinus thrombosis: correlation with venous pressure measurements and implications for treatment and prognosis. AJNR Am J Neuroradiol. 1995;16:1021-1029.
96. Lee SK, terBrugge KG. Cerebral venous thrombosis in adults: the role of imaging evaluation and management. Neuroimaging Clin N Am. 2003;13:139-152. (Pubitemid 36390029)
97. Khandelwal N, Agarwal A, Kochhar R, Bapuraj JR, Singh P, Prabhakar S, Suri S. Comparison of CT venography with MR venography in cerebral sinovenous thrombosis. AJR Am J Roentgenol. 2006;187: 1637-1643. (Pubitemid 44788699)
98. Leys D, Cordonnier C. Cerebral venous thrombosis: update on clinical manifestations, diagnosis and management. Ann Indian Acad Neurol. 2008;11:S79-S87. (Pubitemid 351962388)
99. Oppenheim C, Domigo V, Gauvrit JY, Lamy C, Mackowiak-Cordoliani MA, Pruvo JP, Méder JF. Subarachnoid hemorrhage as the initial presentation of dural sinus thrombosis. AJNR Am J Neuroradiol. 2005;26: 614-617. (Pubitemid 43085967)
100. Poon CS, Chang JK, Swarnkar A, Johnson MH, Wasenko J. Radiologic diagnosis of cerebral venous thrombosis: pictorial review. AJR Am J Roentgenol. 2007;189(suppl):S64-S75. (Pubitemid 350174774)
101. Rodallec MH, Krainik A, Feydy A, Hélias A, Colombani JM, Jullès MC, Marteau V, Zins M. Cerebral venous thrombosis and multidetector CT angiography: tips and tricks. Radiographics. 2006;26(suppl 1):S5-S18.
102. deVeber G, Andrew M, Adams C, Bjornson B, Booth F, Buckley DJ, Camfield CS, David M, Humphreys P, Langevin P, MacDonald EA, Gillett J, Meaney B, Shevell M, Sinclair DB, Yager J; Canadian Pediatric Ischemic Stroke Study Group. Cerebral sinovenous thrombosis in children. N Engl J Med. 2001;345:417-423. (Pubitemid 32747605)
103. Majoie CB, van Straten M, Venema HW, den Heeten GJ. Multisection CT venography of the dural sinuses and cerebral veins by using matched mask bone elimination. AJNR Am J Neuroradiol. 2004;25:787-791. (Pubitemid 38657663)
104. Manzione J, Newman GC, Shapiro A, Santo-Ocampo R. Diffusion-and perfusion-weighted MR imaging of dural sinus thrombosis. AJNR Am J Neuroradiol. 2000;21:68-73. (Pubitemid 30225829)
105. Wasay M, Azeemuddin M. Neuroimaging of cerebral venous thrombosis. J Neuroimaging. 2005;15:118-128. (Pubitemid 40388315)
106. Ozsvath RR, Casey SO, Lustrin ES, Alberico RA, Hassankhani A, Patel M. Cerebral venography: comparison of CT and MR projection venography. AJR Am J Roentgenol. 1997;169:1699-1707. (Pubitemid 127469807)
107. Wetzel SG, Kirsch E, Stock KW, Kolbe M, Kaim A, Radue EW. Cerebral veins: comparative study of CT venography with intraarterial digital subtraction angiography. AJNR Am J Neuroradiol. 1999;20: 249-255. (Pubitemid 30418706)
108. Boukobza M, Crassard I, Bousser MG, Chabriat H. MR imaging features of isolated cortical vein thrombosis: diagnosis and follow-up. AJNR Am J Neuroradiol. 2009;30:344-348.
109. Bousser MG. Cerebral venous thrombosis: diagnosis and management. J Neurol. 2000;247:252-258.
110. Favrole P, Guichard JP, Crassard I, Bousser MG, Chabriat H. Diffusionweighted imaging of intravascular clots in cerebral venous thrombosis. Stroke. 2004;35:99-103. (Pubitemid 38057599)
111. Mullins ME, Grant PE, Wang B, Gonzalez RG, Schaefer PW. Parenchymal abnormalities associated with cerebral venous sinus thrombosis: assessment with diffusion-weighted MR imaging. AJNR Am J Neuroradiol. 2004;25: 1666-1675. (Pubitemid 44123688)
112. Nael K, Fenchel M, Salamon N, Duckwiler GR, Laub G, Finn JP, Villablanca JP. Three-dimensional cerebral contrast-enhanced magnetic resonance venography at 3.0 Tesla: initial results using highly accelerated parallel acquisition. Invest Radiol. 2006;41:763-768. (Pubitemid 44401303)
113. Tomasian A, Salamon N, Krishnam MS, Finn JP, Villablanca JP. 3D high-spatial-resolution cerebral MR venography at 3T: a contrast-dosereduction study. AJNR Am J Neuroradiol. 2009;30:349-355.
114. Lettau M, Sartor K, Heiland S, Hähnel S. 3T high-spatial-resolution contrast-enhanced MR angiography of the intracranial venous system with parallel imaging. AJNR Am J Neuroradiol. 2009;30:185-187.
115. Duncan IC, Fourie PA. Imaging of cerebral isolated cortical vein thrombosis. AJR Am J Roentgenol. 2005;184:1317-1319. (Pubitemid 43821920)
116. Urban PP, Müller-Forell W. Clinical and neuroradiological spectrum of isolated cortical vein thrombosis. J Neurol. 2005;252:1476-1481. (Pubitemid 41803837)
117. Ferro JM, Lopes MG, Rosas MJ, Ferro MA, Fontes J; Cerebral Venous Thrombosis Portuguese Collaborative Study Group. Long-term prognosis of cerebral vein and dural sinus thrombosis: results of the VENOPORT study. Cerebrovasc Dis. 2002;13:272-278. (Pubitemid 34518723)
118. Hinman JM, Provenzale JM. Hypointense thrombus on T2-weighted MR imaging: a potential pitfall in the diagnosis of dural sinus thrombosis. Eur J Radiol. 2002;41:147-152. (Pubitemid 34164136)
119. Selim M, Fink J, Linfante I, Kumar S, Schlaug G, Caplan LR. Diagnosis of cerebral venous thrombosis with echo-planar T2*-weighted magnetic resonance imaging. Arch Neurol. 2002;59:1021-1026. (Pubitemid 34640765)
120. Bianchi D, Maeder P, Bogousslavsky J, Schnyder P, Meuli RA. Diagnosis of cerebral venous thrombosis with routine magnetic resonance: an update. Eur Neurol. 1998;40:179-190. (Pubitemid 28526241)
121. Casey SO, Alberico RA, Patel M, Jimenez JM, Ozsvath RR, Maguire WM, Taylor ML. Cerebral CT venography. Radiology. 1996;198: 163-170. (Pubitemid 26008259)
122. Corvol JC, Oppenheim C, Manä R, Logak M, Dormont D, Samson Y, Marsault C, Rancurel G. Diffusion-weighted magnetic resonance imaging in a case of cerebral venous thrombosis. Stroke. 1998;29: 2649-2652. (Pubitemid 28544019)
123. Hsu LC, Lirng JF, Fuh JL, Wang SJ, Shyu HY, Liu HC. Proton magnetic resonance spectroscopy in deep cerebral venous thrombosis. Clin Neurol Neurosurg. 1998;100:27-30.
124. Keller E, Flacke S, Urbach H, Schild HH. Diffusion-and perfusionweighted magnetic resonance imaging in deep cerebral venous thrombosis. Stroke. 1999;30:1144-1146. (Pubitemid 29211640)
125. Lafitte F, Boukobza M, Guichard JP, Hoeffel C, Reizine D, Ille O, Woimant F, Merland JJ. MRI and MRA for diagnosis and follow-up of cerebral venous thrombosis (CVT). Clin Radiol. 1997;52:672-679.
126. Röther J, Waggie K, van Bruggen N, de Crespigny AJ, Moseley ME. Experimental cerebral venous thrombosis: evaluation using magnetic resonance imaging. J Cereb Blood Flow Metab. 1996;16:1353-1361. (Pubitemid 26365390)
127. Wang AM. MRA of venous sinus thrombosis. Clin Neurosci. 1997;4: 158-164.
128. Yuh WT, Simonson TM, Wang AM, Koci TM, Tali ET, Fisher DJ, Simon JH, Jinkins JR, Tsai F. Venous sinus occlusive disease: MR findings. AJNR Am J Neuroradiol. 1994;15:309-316. (Pubitemid 24070499)
129. Meckel S, Reisinger C, Bremerich J, Damm D, Wolbers M, Engelter S, Scheffler K, Wetzel SG. Cerebral venous thrombosis: diagnostic accuracy of combined, dynamic and static, contrast-enhanced 4D MR. AJNR Am J Neuroradiol. 2010;31:527-535.
130. Doege CA, Tavakolian R, Kerskens CM, Romero BI, Lehmann R, Einhäupl KM, Villringer A. Perfusion and diffusion magnetic resonance imaging in human cerebral venous thrombosis. J Neurol. 2001;248: 564-571. (Pubitemid 32700298)
131. Ducreux D, Oppenheim C, Vandamme X, Dormont D, Samson Y, Rancurel G, Cosnard G, Marsault C. Diffusion-weighted imaging patterns of brain damage associated with cerebral venous thrombosis. AJNR Am J Neuroradiol. 2001;22:261-268. (Pubitemid 32163453)
132. Lövblad KO, Bassetti C, Schneider J, Guzman R, El-Koussy M, Remonda L, Schroth G. Diffusion-weighted MR in cerebral venous thrombosis. Cerebrovasc Dis. 2001;11:169-176. (Pubitemid 32304627)
133. Yoshikawa T, Abe O, Tsuchiya K, Okubo T, Tobe K, Masumoto T, Hayashi N, Mori H, Yamada H, Aoki S, Ohtomo K. Diffusion-weighted magnetic resonance imaging of dural sinus thrombosis. Neuroradiology. 2002;44:481-488. (Pubitemid 36067839)
134. Liauw L, van Buchem MA, Spilt A, de Brüne FT, van den Berg R, Hermans J, Wasser MN. MR angiography of the intracranial venous system. Radiology. 2000;214:678-682. (Pubitemid 30115363)
135. Chu K, Kang DW, Yoon BW, Roh JK. Diffusion-weighted magnetic resonance in cerebral venous thrombosis. Arch Neurol. 2001;58: 1569-1576. (Pubitemid 32963220)
136. Ferro JM, Correia M, Pontes C, Baptista MV, Pita F; Cerebral Venous Thrombosis Portuguese Collaborative Study Group (Venoport). Cerebral vein and dural sinus thrombosis in Portugal: 1980-1998. Cerebrovasc Dis. 2001;11:177-182. (Pubitemid 32304628)
137. Dormont D, Sag K, Biondi A, Wechsler B, Marsault C. Gadoliniumenhanced MR of chronic dural sinus thrombosis. AJNR Am J Neuroradiol. 1995;16:1347-1352.
138. Forbes KP, Pipe JG, Heiserman JE. Evidence for cytotoxic edema in the pathogenesis of cerebral venous infarction. AJNR Am J Neuroradiol. 2001;22:450-455. (Pubitemid 32221407)
139. Ferro JM, Canhão P. Acute treatment of cerebral venous and dural sinus thrombosis. Curr Treat Options Neurol. 2008;10:126-137. (Pubitemid 351460257)
140. Widjaja E, Griffiths PD. Intracranial MR in children: normal anatomy and variations. AJNR Am J Neuroradiol. 2004;25:1557-1562. (Pubitemid 44383610)
141. Suzuki Y, Ikeda H, Shimadu M, Ikeda Y, Matsumoto K. Variations of the basal vein: identification using three-dimensional CT angiography. AJNR Am J Neuroradiol. 2001;22:670-676. (Pubitemid 32318694)
142. Hu HH, Campeau NG, Huston J 3rd, Kruger DG, Haider CR, Riederer SJ. High-spatial-resolution contrast-enhanced MR angiography of the intracranial venous system with fourfold accelerated two-dimensional sensitivity encoding. Radiology. 2007;243:853-861. (Pubitemid 46799441)
143. Idbaih A, Boukobza M, Crassard I, Porcher R, Bousser MG, Chabriat H. MRI of clot in cerebral venous thrombosis: high diagnostic value of susceptibility-weighted images. Stroke. 2006;37:991-995.
144. Farb RI, Scott JN, Willinsky RA, Montanera WJ, Wright GA, terBrugge KG. Intracranial venous system: gadolinium-enhanced threedimensional MR venography with auto-triggered elliptic centric-ordered sequence: initial experience. Radiology. 2003;226:203-209. (Pubitemid 36163930)
145. Kirchhof K, Welzel T, Jansen O, Sartor K. More reliable noninvasive visualization of the cerebral veins and dural sinuses: comparison of three MR angiographic techniques. Radiology. 2002;224:804-810. (Pubitemid 34919817)
146. Liang L, Korogi Y, Sugahara T, Onomichi M, Shigematsu Y, Yang D, Kitajima M, Hiai Y, Takahashi M. Evaluation of the intracranial dural sinuses with a 3D contrast-enhanced MP-RAGE sequence: prospective comparison with 2D-TOF MR venography and digital subtraction angiography. AJNR Am J Neuroradiol. 2001;22:481-492. (Pubitemid 32221412)
147. Isensee C, Reul J, Thron A. Magnetic resonance imaging of thrombosed dural sinuses. Stroke. 1994;25:29-34.
148. Lewin JS, Masaryk TJ, Smith AS, Ruggieri PM, Ross JS. Time-of-flight intracranial MR venography: evaluation of the sequential oblique section technique. AJNR Am J Neuroradiol. 1994;15:1657-1664. (Pubitemid 24311415)
149. Vogl TJ, Bergman C, Villringer A, Einhäupl K, Lissner J, Felix R. Dural sinus thrombosis: value of venous MR angiography for diagnosis and follow-up. AJR Am J Roentgenol. 1994;162:1191-1198. (Pubitemid 24144997)
150. Wasenko JJ, Holsapple JW, Winfield JA. Cerebral venous thrombosis: demonstration with magnetic resonance angiography. Clin Imaging. 1995;19:153-161.
151. Rizzo L, Crasto SG, Rudà R, Gallo G, Tola E, Garabello D, De Lucchi R. Cerebral venous thrombosis: role of CT, MRI and MRA in the emergency setting. Radiol Med. 2010;115:313-325.
152. Hsu HY, Wang PY, Chen CC, Hu HH. Dural arteriovenous fistula after cerebral sinus thrombosis: a case study of serial venous transcranial color-coded sonography. J Ultrasound Med. 2004;23:1095-1100. (Pubitemid 39014786)
153. Leach JL, Strub WM, Gaskill-Shipley MF. Cerebral venous thrombus signal intensity and susceptibility effects on gradient recalled-echo MR imaging. AJNR Am J Neuroradiol. 2007;28:940-945. (Pubitemid 46776080)
154. Komiyama M, Ishiguro T, Kitano S, Sakamoto H, Nakamura H. Serial antenatal sonographic observation of cerebral dural sinus malformation. AJNR Am J Neuroradiol. 2004;25:1446-1448. (Pubitemid 44364361)
155. Schwartz N, Monteagudo A, Bornstein E, Timor-Tritsch IE, Zagzag D, Kudla M. Thrombosis of an ectatic torcular herophili: anatomic localization using fetal neurosonography. J Ultrasound Med. 2008;27: 989-991. (Pubitemid 351913841)
156. Schaller B, Graf R, Sanada Y, Tolnay M, Rosner G, Wienhard K, Heiss WD. Hemodynamic changes after occlusion of the posterior superior sagittal sinus: an experimental PET study in cats. AJNR Am J Neuroradiol. 2003;24:1876-1880. (Pubitemid 37280540)
157. Kawai N, Shindou A, Masada T, Tamiya T, Nagao S. Hemodynamic and metabolic changes in a patient with cerebral venous sinus thrombosis: evaluation using O-15 positron emission tomography. Clin Nucl Med. 2005;30:391-394. (Pubitemid 40733996)
158. Liang L, Korogi Y, Sugahara T, Ikushima I, Shigematsu Y, Takahashi M, Provenzale JM. Normal structures in the intracranial dural sinuses: delineation with 3D contrast-enhanced magnetization prepared rapid acquisition gradient-echo imaging sequence. AJNR Am J Neuroradiol. 2002;23:1739-1746. (Pubitemid 35304114)
159. Zouaoui A, Hidden G. Cerebral venous sinuses: anatomical variants or thrombosis? Acta Anat (Basel). 1988;133:318-324. (Pubitemid 19037187)
160. Ayanzen RH, Bird CR, Keller PJ, McCully FJ, Theobald MR, Heiserman JE. Cerebral MR venography: normal anatomy and potential diagnostic pitfalls. AJNR Am J Neuroradiol. 2000;21:74-78. (Pubitemid 30225830)
161. Stam J, De Bruijn SF, DeVeber G. Anticoagulation for cerebral sinus thrombosis. Cochrane Database Syst Rev. 2002;(4):CD002005.
162. Rice D, Swisher S, Pisters K, Fossella F, Herbst R, Hofstetter W, Kies M, Komaki R, Lippman S, Mehran R, Roth J, Stewart D, Vaporciyan A, Walsh G, Cox J. Comment on "Treatment of non-small cell lung cancer stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition)." Chest. 2008;134:1349, author reply 1350.
163. Dunn W, Murphy JG. Simulation: about safety, not fantasy. Chest. 2008;133:6-9.
164. Einhäupl K, Bousser MG, de Bruijn SF, Ferro JM, Martinelli I, Masuhr F, Stam J. EFNS guideline on the treatment of cerebral venous and sinus thrombosis. Eur J Neurol. 2006;13:553-559. (Pubitemid 43873627)
165. Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, Grubb RL, Higashida RT, Jauch EC, Kidwell C, Lyden PD, Morgenstern LB, Qureshi AI, Rosenwasser RH, Scott PA, Wijdicks EF. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups [published correction appears in Stroke. 2007;38:e38 and Stroke. 2007;38:e96]. Stroke. 2007;38:1655-1711. (Pubitemid 46691097)
166. Stroke Unit Trialists' Collaboration. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev. 2007 Oct 17;(4): CD000197.
167. Stroke Unit Trialists' Collaboration. How do stroke units improve patient outcomes? A collaborative systematic review of the randomized trials. Stroke Unit Trialists Collaboration. Stroke. 1997;28:2139-2144.
168. Saposnik G, Fang J, O'Donnell M, Hachinski V, Kapral MK, Hill MD; Investigators of the Registry of the Canadian Stroke Network (RCSN) for the Stroke Outcome Research Canada (SORCan) Working Group. Escalating levels of access to in-hospital care and stroke mortality. Stroke. 2008;39:2522-2530.
169. Saposnik G, Kapral MK, Coutts SB, Fang J, Demchuk AM, Hill MD; Investigators of the Registry of the Canadian Stroke Network (RCSN) for the Stroke Outcome Research Canada (SORCan) Working Group. Do all age groups benefit from organized inpatient stroke care? Stroke. 2009;40:3321-3327.
170. Smith EE, Hassan KA, Fang J, Selchen D, Kapral MK, Saposnik G; Registry of the Canadian Stroke Network (RCSN); Stroke Outcome Research Canada (SORCan) Working Group. Do all ischemic stroke subtypes benefit from organized inpatient stroke care? Neurology. 2010; 75:456-462.
171. Einhäupl KM, Villringer A, Meister W, Mehraein S, Garner C, Pellkofer M, Haberl RL, Pfister HW, Schmiedek P. Heparin treatment in sinus venous thrombosis [published correction appears in Lancet. 1991; 338:958]. Lancet. 1991;338:597-600.
172. de Bruijn SF, Stam J. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke. 1999;30:484-488. (Pubitemid 29115380)
173. de Bruijn SF, Budde M, Teunisse S, de Haan RJ, Stam J. Long-term outcome of cognition and functional health after cerebral venous sinus thrombosis. Neurology. 2000;54:1687-1689. (Pubitemid 30226818)
174. Daif A, Awada A, al-Rajeh S, Abduljabbar M, al Tahan AR, Obeid T, Malibary T. Cerebral venous thrombosis in adults: a study of 40 cases from Saudi Arabia. Stroke. 1995;26:1193-1195.
175. Preter M, Tzourio C, Ameri A, Bousser MG. Long-term prognosis in cerebral venous thrombosis: follow-up of 77 patients. Stroke. 1996;27: 243-246. (Pubitemid 26044494)
176. Maqueda VM, Thijs V. Risk of thromboembolism after cerebral venous thrombosis. Eur J Neurol. 2006;13:302-305.
177. Breteau G, Mounier-Vehier F, Godefroy O, Gauvrit JY, Mackowiak-Cordoliani MA, Girot M, Bertheloot D, Hénon H, Lucas C, Leclerc X, Fourrier F, Pruvo JP, Leys D. Cerebral venous thrombosis 3-year clinical outcome in 55 consecutive patients. J Neurol. 2003;250:29-35. (Pubitemid 36206681)
178. Cakmak S, Derex L, Berruyer M, Nighoghossian N, Philippeau F, Adeleine P, Hermier M, Froment JC, Trouillas P. Cerebral venous thrombosis: clinical outcome and systematic screening of prothrombotic factors. Neurology. 2003;60:1175-1178. (Pubitemid 36418782)
179. Stolz E, Rahimi A, Gerriets T, Kraus J, Kaps M. Cerebral venous thrombosis: an all or nothing disease? Prognostic factors and long-term outcome. Clin Neurol Neurosurg. 2005;107:99-107. (Pubitemid 40228968)
180. Mak W, Mok KY, Tsoi TH, Cheung RT, Ho SL, Chang CM. Cerebral venous thrombosis in Hong Kong. Cerebrovasc Dis. 2001;11:282-283. (Pubitemid 32304644)
181. Brucker AB, Vollert-Rogenhofer H, Wagner M, Stieglbauer K, Felber S, Trenkler J, Deisenhammer E, Aichner F. Heparin treatment in acute cerebral sinus venous thrombosis: a retrospective clinical and MR analysis of 42 cases. Cerebrovasc Dis. 1998;8:331-337. (Pubitemid 28491094)
182. Nagaraja D, Rao BSS, Taly AB. Randomized controlled trial of heparin in therapy of cerebral venous/sinus thrombosis. Nimhans J. 1995;13: 111-115.
183. Ameri A, Bousser MG. Cerebral venous thrombosis. Neurol Clin. 1992; 10:87-111.
184. van Dongen CJ, van den Belt AG, Prins MH, Lensing AW. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. Cochrane Database Syst Rev. 2004 Oct 18;(4):CD001100.
185. Masuhr F, Einhäupl K. Treatment of cerebral venous and sinus thrombosis. Front Neurol Neurosci. 2008;23:132-143.
186. Röttger C, Trittmacher S, Gerriets T, Blaes F, Kaps M, Stolz E. Reversible MR imaging abnormalities following cerebral venous thrombosis. AJNR Am J Neuroradiol. 2005;26:607-613. (Pubitemid 43085966)
187. Sébire G, Tabarki B, Saunders DE, Leroy I, Liesner R, Saint-Martin C, Husson B, Williams AN, Wade A, Kirkham FJ. Cerebral venous sinus thrombosis in children: risk factors, presentation, diagnosis and outcome. Brain. 2005;128(part 3):477-489. (Pubitemid 40380184)
188. Bousser MG. Cerebral venous thrombosis: nothing, heparin, or local thrombolysis? Stroke. 1999;30:481-483.
189. Frey JL, Muro GJ, McDougall CG, Dean BL, Jahnke HK. Cerebral venous thrombosis: combined intrathrombus rtPA and intravenous heparin. Stroke. 1999;30:489-494. (Pubitemid 29115381)
190. Mehraein S, Schmidtke K, Villringer A, Valdueza JM, Masuhr F. Heparin treatment in cerebral sinus and venous thrombosis: patients at risk of fatal outcome. Cerebrovasc Dis. 2003;15:17-21. (Pubitemid 36131894)
191. Stam J, de Bruijn S, deVeber G. Anticoagulation for cerebral sinus thrombosis. Stroke. 2003;34:1054-1055. (Pubitemid 36402990)
192. Stolz E, Trittmacher S, Rahimi A, Gerriets T, Röttger C, Siekmann R, Kaps M. Influence of recanalization on outcome in dural sinus thrombosis: a prospective study. Stroke. 2004;35:544-547. (Pubitemid 38174446)
193. Baumgartner RW, Studer A, Arnold M, Georgiadis D. Recanalisation of cerebral venous thrombosis. J Neurol Neurosurg Psychiatry. 2003;74: 459-461. (Pubitemid 36379367)
194. Strupp M, Covi M, Seelos K, Dichgans M, Brandt T. Cerebral venous thrombosis: correlation between recanalization and clinical outcome: a long-term follow-up of 40 patients. J Neurol. 2002;249:1123-1124. (Pubitemid 35002245)
195. Bagley LJ, Hurst RW, Galetta S, Teener J, Sinson GP. Use of a microsnare to aid direct thrombolytic therapy of dural sinus thrombosis. AJR Am J Roentgenol. 1998;170:784-786. (Pubitemid 28106683)
196. Canevini MP, De Sarro G, Galimberti CA, Gatti G, Licchetta L, Malerba A, Muscas G, La Neve A, Striano P, Perucca E; SOPHIE Study Group. Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy. Epilepsia. 2010;51:797-804.
197. Ferro JM, Canhão P, Bousser MG, Stam J, Barinagarrementeria F; ISCVT Investigators. Early seizures in cerebral vein and dural sinus thrombosis: risk factors and role of antiepileptics. Stroke. 2008;39: 1152-1158. (Pubitemid 351440684)
198. Bousser MG, Russell RR. Pathology and pathogenesis of venous infarction. In: Bousser MG, ed. Cerebral Venous Thrombosis. Paris VI Univ, Paris, France: WB Saunders Company; 1997:20-21.
199. Hanley DF, Feldman E, Borel CO, Rosenbaum AE, Goldberg AL. Treatment of sagittal sinus thrombosis associated with cerebral hemorrhage and intracranial hypertension. Stroke. 1988;19:903-909.
200. Keller E, Pangalu A, Fandino J, Könü D, Yonekawa Y. Decompressive craniectomy in severe cerebral venous and dural sinus thrombosis. Acta Neurochir Suppl. 2005;94:177-183.
201. Kersbergen KJ, de Vries LS, van Straaten HL, Benders MJ, Nievelstein RA, Groenendaal F. Anticoagulation therapy and imaging in neonates with a unilateral thalamic hemorrhage due to cerebral sinovenous thrombosis. Stroke. 2009;40:2754-2760.
202. Lanterna LA, Gritti P, Manara O, Grimod G, Bortolotti G, Biroli F. Decompressive surgery in malignant dural sinus thrombosis: report of 3 cases and review of the literature. Neurosurg Focus. 2009;26:E5.
203. Stefini R, Latronico N, Cornali C, Rasulo F, Bollati A. Emergent decompressive craniectomy in patients with fixed dilated pupils due to cerebral venous and dural sinus thrombosis: report of three cases. Neurosurgery. 1999;45:626-629.
204. Vahedi K, Hofmeijer J, Juettler E, Vicaut E, George B, Algra A, Amelink GJ, Schmiedeck P, Schwab S, Rothwell PM, Bousser MG, van der Worp HB, Hacke W; DECIMAL, DESTINY, and HAMLET Investigators. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol. 2007;6:215-222. (Pubitemid 46237760)
205. Wu YW, Hamrick SE, Miller SP, Haward MF, Lai MC, Callen PW, Barkovich AJ, Ferriero DM. Intraventricular hemorrhage in term neonates caused by sinovenous thrombosis. Ann Neurol. 2003;54: 123-126. (Pubitemid 36764990)
206. Canhão P, Falcão F, Ferro JM. Thrombolytics for cerebral sinus thrombosis: a systematic review. Cerebrovasc Dis. 2003;15:159-166. (Pubitemid 36351200)
207. Chaloupka JC, Mangla S, Huddle DC. Use of mechanical thrombolysis via microballoon percutaneous transluminal angioplasty for the treatment of acute dural sinus thrombosis: case presentation and technical report. Neurosurgery. 1999;45:650-656.
208. Stam J, Majoie CB, van Delden OM, van Lienden KP, Reekers JA. Endovascular thrombectomy and thrombolysis for severe cerebral sinus thrombosis: a prospective study. Stroke. 2008;39:1487-1490.
209. Messé SR, Sansing LH, Cucchiara BL, Herman ST, Lyden PD, Kasner SE; CHANT Investigators. Prophylactic antiepileptic drug use is associated with poor outcome following ICH. Neurocrit Care. 2009;11: 38-44.
210. Martinelli I, Bucciarelli P, Passamonti SM, Battaglioli T, Previtali E, Mannucci PM. Long-term evaluation of the risk of recurrence after cerebral sinus-venous thrombosis. Circulation. 2010;121:2740-2746.
211. Wysokinska EM, Wysokinski WE, Brown RD, Karnicki K, Gosk-Beirska I, Grill D, McBane RD 2nd. Thrombophilia differences in cerebral venous sinus and lower extremity deep venous thrombosis. Neurology. 2008;70:627-633. (Pubitemid 351294640)
212. Choulakian A, Alexander MJ. Mechanical thrombectomy with the penumbra system for treatment of venous sinus thrombosis. J NeuroIntervent Surg. 2010;2:153-156.
213. Persson L, Lilja A. Extensive dural sinus thrombosis treated by surgical removal and local streptokinase infusion. Neurosurgery. 1990;26: 117-121. (Pubitemid 20209548)
214. Ekseth K, Boström S, Vegfors M. Reversibility of severe sagittal sinus thrombosis with open surgical thrombectomy combined with local infusion of tissue plasminogen activator: technical case report. Neurosurgery. 1998; 43:960-965.
215. Coutinho JM, Majoie CB, Coert BA, Stam J. Decompressive hemicraniectomy in cerebral sinus thrombosis: consecutive case series and review of the literature. Stroke. 2009;40:2233-2235.
216. Canhão P, Cortesão A, Cabral M, Ferro JM, Stam J, Bousser MG, Barinagarrementeria F; ISCVT Investigators. Are steroids useful to treat cerebral venous thrombosis? Stroke. 2008;39:105-110.
217. Masuhr F, Busch M, Amberger N, Ortwein H, Weih M, Neumann K, Einhäupl K, Mehraein S. Risk and predictors of early epileptic seizures in acute cerebral venous and sinus thrombosis. Eur J Neurol. 2006;13: 852-856. (Pubitemid 44124681)
218. Ferro JM, Correia M, Rosas MJ, Pinto AN, Neves G; Cerebral Venous Thrombosis Portuguese Collaborative Study Group (Venoport). Seizures in cerebral vein and dural sinus thrombosis. Cerebrovasc Dis. 2003;15: 78-83. (Pubitemid 36131902)
219. Miranda B, Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F, Scoditti U; ISCVT Investigators. Venous thromboembolic events after cerebral vein thrombosis. Stroke. 2010;41:1901-1906.
220. Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) [published correction appears in Chest. 2008; 134:892]. Chest. 2008;133(suppl):454S-545S. (Pubitemid 351892971)
221. Lijfering WM, Brouwer JL, Veeger NJ, Bank I, Coppens M, Middeldorp S, Hamulyák K, Prins MH, Büller HR, van der Meer J. Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives. Blood. 2009; 113:5314-5322.
222. Mackie I, Cooper P, Kitchen S. Quality assurance issues and interpretation of assays. Semin Hematol. 2007;44:114-125. (Pubitemid 46551190)
223. Goodwin AJ, Rosendaal FR, Kottke-Marchant K, Bovill EG. A review of the technical, diagnostic, and epidemiologic considerations for protein S assays. Arch Pathol Lab Med. 2002;126:1349-1366. (Pubitemid 36237285)
224. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, De Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4:295-306.
225. Lim W, Crowther MA, Eikelboom JW. Management of antiphospholipid antibody syndrome: a systematic review. JAMA. 2006;295: 1050-1057.
226. Asherson RA, Cervera R, de Groot PG, Erkan D, Boffa MC, Piette JC, Khamashta MA, Shoenfeld Y; Catastrophic Antiphospholipid Syndrome Registry Project Group. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus. 2003;12:530-534. (Pubitemid 36890145)
227. Schulman S, Svenungsson E, Granqvist S; Duration of Anticoagulation Study Group. Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Am J Med. 1998;104:332-338. (Pubitemid 28211022)
228. Kearon C, Gent M, Hirsh J, Weitz J, Kovacs MJ, Anderson DR, Turpie AG, Green D, Ginsberg JS, Wells P, MacKinnon B, Julian JA. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism [published correction appears in N Engl J Med. 1999;341:298]. N Engl J Med. 1999;340:901-907. (Pubitemid 29141050)
229. Shrivastava S, Ridker PM, Glynn RJ, Goldhaber SZ, Moll S, Bounameaux H, Bauer KA, Kessler CM, Cushman M. D-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolism. J Thromb Haemost. 2006;4:1208-1214.
230. Palareti G, Legnani C, Cosmi B, Valdré L, Lunghi B, Bernardi F, Coccheri S. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia. Circulation. 2003;108:313-318. (Pubitemid 36899022)
231. Palareti G, Cosmi B, Legnani C, Tosetto A, Brusi C, Iorio A, Pengo V, Ghirarduzzi A, Pattacini C, Testa S, Lensing AW, Tripodi A; PROLONG Investigators. D-dimer testing to determine the duration of anticoagulation therapy [published correction appears in N Engl J Med. 2006;355:2797]. N Engl J Med. 2006;355:1780-1789. (Pubitemid 44631361)
232. Wakai A, Gleeson A, Winter D. Role of fibrin D-dimer testing in emergency medicine. Emerg Med J. 2003;20:319-325. (Pubitemid 36873905)
233. Buccino G, Scoditti U, Patteri I, Bertolino C, Mancia D. Neurological and cognitive long-term outcome in patients with cerebral venous sinus thrombosis. Acta Neurol Scand. 2003;107:330-335. (Pubitemid 36628356)
234. Ferro JM, Vasconcelos J, Canhão P, Bousser MG, Stam J, Barinagarrementeria F; ISCVT Investigators. Remote seizures in acute cerebral vein and dural sinus thrombosis (CVT): incidence and associated conditions. Cerebrovasc Dis. 2007;23(suppl 2):48. Abstract.
235. Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F, Massaro A, Ducrocq X, Kasner SE; ISCVT Investigators. Delay in the diagnosis of cerebral vein and dural sinus thrombosis: influence on outcome. Stroke. 2009;40:3133-3138.
236. Phatouros CC, Halbach VV, Dowd CF, Lempert TE, Malek AM, Meyers PM, Higashida RT. Acquired pial arteriovenous fistula following cerebral vein thrombosis. Stroke. 1999;30:2487-2490. (Pubitemid 29517753)
237. Kenet G, Waldman D, Lubetsky A, Kornbrut N, Khalil A, Koren A, Wolach B, Fattal A, Kapelushnik J, Tamary H, Yacobovitch J, Raveh E, Revel-Vilk S, Toren A, Brenner B. Paediatric cerebral sinus vein thrombosis: a multi-center, case-controlled study. Thromb Haemost. 2004;92: 713-718. (Pubitemid 39386695)
238. Françcois P, Fabre M, Lioret E, Jan M. Vascular cerebral thrombosis during pregnancy and post-partum [in French]. Neurochirurgie. 2000; 46:105-109. (Pubitemid 30407390)
239. Lanska DJ, Kryscio RJ. Peripartum stroke and intracranial venous thrombosis in the National Hospital Discharge Survey. Obstet Gynecol. 1997;89:413-418. (Pubitemid 27086098)
240. Wilterdink JL, Easton JD. Cerebral ischemia in pregnancy. Adv Neurol. 2002;90:51-62.
241. Jeng JS, Tang SC, Yip PK. Incidence and etiologies of stroke during pregnancy and puerperium as evidenced in Taiwanese women. Cerebrovasc Dis. 2004;18:290-295.
242. Bates SM, Greer IA, Pabinger I, Sofaer S, Hirsh J. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(suppl):844S-886S. (Pubitemid 351892978)
243. Ni Ainle F, Wong A, Appleby N, Byrne B, Regan C, Hassan T, Milner M, Sullivan AO, White B, O'Donnell J. Efficacy and safety of once daily low molecular weight heparin (tinzaparin sodium) in high risk pregnancy. Blood Coagul Fibrinolysis. 2008;19:689-692.
244. Niwa J, Ohyama H, Matumura S, Maeda Y, Shimizu T. Treatment of acute superior sagittal sinus thrombosis by t-PA infusion via venography: direct thrombolytic therapy in the acute phase. Surg Neurol. 1998; 49:425-429. (Pubitemid 28153022)
245. López JA, Kearon C, Lee AY. Deep venous thrombosis. Hematology Am Soc Hematol Educ Program. 2004:439-456.
246. Kenet G, Kirkham F, Niederstadt T, Heinecke A, Saunders D, Stoll M, Brenner B, Bidlingmaier C, Heller C, Knöfler R, Schobess R, Zieger B, Sébire G, Nowak-Göttl U; European Thromboses Study Group. Risk factors for recurrent venous thromboembolism in the European collaborative paediatric database on cerebral venous thrombosis: a multicentre cohort study. Lancet Neurol. 2007;6:595-603. (Pubitemid 46921043)
247. Lamy C, Hamon JB, Coste J, Mas JL; French Study Group on Stroke in Pregnancy. Ischemic stroke in young women: risk of recurrence during subsequent pregnancies. Neurology. 2000;55:269-274. (Pubitemid 30604629)
248. Mehraein S, Ortwein H, Busch M, Weih M, Einhäupl K, Masuhr F. Risk of recurrence of cerebral venous and sinus thrombosis during subsequent pregnancy and puerperium. J Neurol Neurosurg Psychiatry. 2003;74: 814-816. (Pubitemid 36628304)
249. Srinivasan K. Cerebral venous and arterial thrombosis in pregnancy and puerperium: a study of 135 patients. Angiology. 1983;34:731-746. (Pubitemid 14205489)
250. Barnes C, Newall F, Furmedge J, Mackay M, Monagle P. Cerebral sinus venous thrombosis in children. J Paediatr Child Health. 2004;40:53-55. (Pubitemid 38333597)
251. Kenet G, Lütkhoff LK, Albisetti M, Bernard T, Bonduel M, Brandao L, Chabrier S, Chan A, deVeber G, Fiedler B, Fullerton HJ, Goldenberg NA, Grabowski E, Günther G, Heller C, Holzhauer S, Iorio A, Journeycake J, Junker R, Kirkham FJ, Kurnik K, Lynch JK, Male C, Manco-Johnson M, Mesters R, Monagle P, van Ommen CH, Raffini L, Rostásy K, Simioni P, Sträter RD, Young G, Nowak-Göttl U. Impact of thrombophilia on risk of arterial ischemic stroke or cerebral sinovenous thrombosis in neonates and children: a systematic review and meta-analysis of observational studies. Circulation. 2010;121:1838-1847.
252. Simchen MJ, Goldstein G, Lubetsky A, Strauss T, Schiff E, Kenet G. Factor V Leiden and antiphospholipid antibodies in either mothers or infants increase the risk for perinatal arterial ischemic stroke. Stroke. 2009;40:65-70.
253. Wu YW, Miller SP, Chin K, Collins AE, Lomeli SC, Chuang NA, Barkovich AJ, Ferriero DM. Multiple risk factors in neonatal sinovenous thrombosis. Neurology. 2002;59:438-440. (Pubitemid 34857940)
254. Fitzgerald KC, Williams LS, Garg BP, Carvalho KS, Golomb MR. Cerebral sinovenous thrombosis in the neonate. Arch Neurol. 2006;63: 405-409.
255. Maguire JL, deVeber G, Parkin PC. Association between irondeficiency anemia and stroke in young children. Pediatrics. 2007;120: 1053-1057. (Pubitemid 350085539)
256. Shroff M, deVeber G. Sinovenous thrombosis in children. Neuroimaging Clin N Am. 2003;13:115-138. (Pubitemid 36390028)
257. Widjaja E, Shroff M, Blaser S, Laughlin S, Raybaud C. 2D time-offlight MR venography in neonates: anatomy and pitfalls. AJNR Am J Neuroradiol. 2006;27:1913-1918. (Pubitemid 44556508)
258. Tsao PN, Lee WT, Peng SF, Lin JH, Yau KI. Power Doppler ultrasound imaging in neonatal cerebral venous sinus thrombosis. Pediatr Neurol. 1999;21:652-655.
259. Volpe JJ. Neurology of the Newborn. Philadelphia, Pa: Saunders; 2001.
260. Carvalho KS, Bodensteiner JB, Connolly PJ, Garg BP. Cerebral venous thrombosis in children. J Child Neurol. 2001;16:574-580. (Pubitemid 32798880)
261. De Schryver EL, Blom I, Braun KP, Kappelle LJ, Rinkel GJ, Peters AC, Jennekens-Schinkel A. Long-term prognosis of cerebral venous sinus thrombosis in childhood. Dev Med Child Neurol. 2004;46:514-519. (Pubitemid 39077131)
262. Azin H, Ashjazadeh N. Cerebral venous sinus thrombosis: clinical features, predisposing and prognostic factors. Acta Neurol Taiwan. 2008;17:82-87. (Pubitemid 351976189)
263. Lobo SN, Bhargava B. Visual loss and associated ocular manifestations of cerebral venous thrombosis. AIOC 2008 Proc. 2008:360-361.
264. Rousseaux M, Cabaret M, Bernati T, Pruvo JP, Steinling M. Residual deficit of verbal recall after a left internal cerebral vein infarct [in French]. Rev Neurol (Paris). 1998;154:401-407. (Pubitemid 28332243)
265. Moharir M, Shroff M, Stephens D, Pontigon AM, Chan A, MacGregor D, Mikulis D, Adams M, deVeber G. Anticoagulants in pediatric cerebral sinovenous thrombosis: a safety and outcome study. Ann Neurol. 2010;67:590-599.
266. International Pediatric Stroke Study Web database. https:// app3.ccb.sickkids.ca/cstrokestudy/. Accessed June 17, 2009.
267. Golomb MR, Fullerton HJ, Nowak-Gottl U, Deveber G; International Pediatric Stroke Study Group. Male predominance in childhood ischemic stroke: findings from the International Pediatric Stroke Study. Stroke. 2009;40:52-57.
268. Roach ES, Golomb MR, Adams R, Biller J, Daniels S, Deveber G, Ferriero D, Jones BV, Kirkham FJ, Scott RM, Smith ER. Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young [published correction appears in Stroke. 2009;40:e8-e10]. Stroke. 2008;39: 2644-2691.
269. Paediatric Stroke Working Group. Stroke in childhood: clinical guidelines for diagnosis, management and rehabilitation, 2004. http://www.rcplondon.ac.uk/ pubs/books/childstroke/. Accessed November 9, 2010.
270. Monagle P, Chalmers E, Chan A, DeVeber G, Kirkham F, Massicotte P, Michelson AD. Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(suppl):887S-68S.
271. Bienfait HP, Stam J, Lensing AW, van Hilten JJ. Thrombosis of the cerebral veins and sinuses in 62 patients [in Dutch]. Ned Tijdschr Geneeskd. 1995;139:1286-1291.
272. Lleó A, Martí-Fàbregas J, Guardia E, Martí-Vilalta JL. Cerebral venous thrombosis: study of 17 cases [in Spanish]. Med Clin (Barc). 1999;113: 537-540.
273. Masuhr F, Mehraein S. Cerebral venous and sinus thrombosis: patients with a fatal outcome during intravenous dose-adjusted heparin treatment. Neurocrit Care. 2004;1:355-361. (Pubitemid 41278351)
274. Stolz E, Kemkes-Matthes B, Pötzsch B, Hahn M, Kraus J, Wirbartz A, Kaps M. Screening for thrombophilic risk factors among 25 German patients with cerebral venous thrombosis. Acta Neurol Scand. 2000;102:31-36. (Pubitemid 30413147)
275. Yang J, Zhou JX, Zhou ZW, Li GL, Yang XS. Clinical features and prognosis of cerebral venous thrombosis [in Chinese]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2008;33:365-368.
276. Rondepierre P, Hamon M, Leys D, Leclerc X, Mounier-Vehier F, Godefroy O, Janssens E, Pruvo JP. Cerebral venous thromboses: study of the course [in French]. Rev Neurol (Paris). 1995;151:100-104.
277. Stolz E, Gerriets T, Bödeker RH, Hügens-Penzel M, Kaps M. Intracranial venous hemodynamics is a factor related to a favorable outcome in cerebral venous thrombosis. Stroke. 2002;33:1645-1650. (Pubitemid 34619972)
278. de Bruijn SF, de Haan RJ, Stam J; for the Cerebral Venous Sinus Thrombosis Study Group. Clinical features and prognostic factors of cerebral venous sinus thrombosis in a prospective series of 59 patients. J Neurol Neurosurg Psychiatry. 2001;70:105-108. (Pubitemid 32096130)
279. Crassard I, Canhão P, Ferro JM, Bousser MG, Barinagarrementeria F, Stam J. Neurological worsening in the acute phase of cerebral venous thrombosis in ISCVT (International Study on Cerebral Venous Thrombosis). Cerebrovasc Dis. 2003;16(suppl 4):60. Abstract.
280. Diaz JM, Schiffman JS, Urban ES, Maccario M. Superior sagittal sinus thrombosis and pulmonary embolism: a syndrome rediscovered. Acta Neurol Scand. 1992;86:390-396.
281. Vucic S, Lye T, Mackenzie RA. Neuropsychological manifestations in a case of bilateral thalamic infarction. J Clin Neurosci. 2003;10: 238-242. (Pubitemid 36358376)
282. Barinagerrementeria F, Carlos C, Arrendondo H. Aseptic cerebral venous thrombosis: proposed prognostic scale. J Stroke Cerebrovasc Dis. 1992;2:34-39.
283. Ferro JM, Bacelar-Nicolau H, Rodrigues T, Bacelar-Nicolau L, Canhão P, Crassard I, Bousser MG, Dutra AP, Massaro A, Mackowiack-Cordiolani MA, Leys D, Fontes J, Stam J, Barinagarrementeria F; ISCVT and VENOPORT Investigators. Risk score to predict the outcome of patients with cerebral vein and dural sinus thrombosis. Cerebrovasc Dis. 2009;28:39-44.
284. Dentali F, Gianni M, Crowther MA, Ageno W. Natural history of cerebral vein thrombosis: a systematic review. Blood. 2006;108: 1129-1134. (Pubitemid 44232006)
285. Koopman K, Uyttenboogaart M, Vroomen PC, van der Meer J, De Keyser J, Luijckx GJ. Development and validation of a predictive outcome score of cerebral venous thrombosis. J Neurol Sci. 2009;276: 66-68.
286. Furie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, Fagan SC, Halperin JL, Johnston SC, Katzan I, Kernan WN, Mitchell PH, Ovbiagele B, Palesch YY, Sacco RL, Schwamm LH, Wassertheil-Smoller S, Turan TN, Wentworth D; Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/ American Stroke Association. Stroke. 2011;42:227-276.